General Information of Drug (ID: DMAPUZY)

Drug Name
AAV1-FS344 Drug Info
Indication
Disease Entry ICD 11 Status REF
Duchenne dystrophy 8C70 Phase 1/2 [1]
Inclusion body myositis 4A41.2 Phase 1/2 [1]
Macular degeneration 9B78.3 Phase 1/2 [2]
Cross-matching ID
TTD Drug ID
DMAPUZY

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Myostatin (MSTN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
SRK-015 DMYAXNM Spinal muscular atrophy 8B61 Phase 2 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Myostatin (MSTN) TTM8I2X GDF8_HUMAN Modulator [3]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037187)
3 Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates. Sci Transl Med. 2009 November 11; 1(6): 6ra15.
4 Clinical pipeline report, company report or official report of Scholar Rock.